Updated on 27 February 2013
This uniquely built facility today services more than 50 percent of the blood product requirement of the country and RLS can now boast of being the only ‘blood refinery', whose products are being used by physicians and surgeons across several countries in the world. Dr Viswanathan has also been handling the administrative aspect of the proceedings by being closely involved with most of the blood banks in the country to source plasma for the fractionation plant.
In recent times, she has been exploring the next frontier of stem cells to address unmet medical needs in the Indian patient population. The regenerative medicine group is currently researching various avenues for the use of autologus and allogenic transplant of stem cells for the treatment of clinical disorders. The department has introduced a variety of products that are aimed at addressing specific needs in the areas of ophthalmology, cardiac disorders and more.
Apart from being felicitated with a number of awards, Dr Viswanathan has published over 60 full text publications in academic journals and has been invited as speaker at several national and international meetings and symposia, in the area of blood banking, stem cell banking and plasma fractionation. About her success and future endeavors, she sums it up by saying, "Success has become my habit and I have been extremely lucky so far in being successful in any new venture that I have undertaken."